XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Nov. 22, 2021
shares
Sep. 20, 2021
item
shares
Apr. 18, 2021
shares
Feb. 28, 2022
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Dec. 02, 2020
shares
Aug. 04, 2020
shares
Stockholders' Equity [Line Items]                  
Common Stock Shares Issued         224,329,000   220,978,000    
Proceeds From Issuance Of Common Stock | $         $ 5,592 $ 22,343      
Common Stock Par Or Stated Value Per Share | $ / shares         $ 0.001   $ 0.001    
Omniome Plan [Member]                  
Stockholders' Equity [Line Items]                  
Exchange ratio | item   0.259204639              
Shares authorized   2,494,128              
ESPP [Member]                  
Stockholders' Equity [Line Items]                  
Shares issued         1,316,923 983,180      
Additional common stock reserved for issuance       4,000,000.0          
Common stock remain available for issuance         10,493,750        
Stock-based compensation expense | $         $ 3,300        
2020 Equity Incentive Plan [Member]                  
Stockholders' Equity [Line Items]                  
Shares authorized                 11,000,000
Common stock remain available for issuance         1,200,000        
2020 Inducement Equity Incentive Plan [Member]                  
Stockholders' Equity [Line Items]                  
Shares authorized               2,500,000  
Additional common stock reserved for issuance 360,000   750,000            
Time-based and performance-based options [Member]                  
Stockholders' Equity [Line Items]                  
Stock-based compensation expense | $         $ 7,500        
Options to purchase common stock [Member]                  
Stockholders' Equity [Line Items]                  
Weighted average grant date fair value per share | $ / shares         $ 6.66 $ 20.21      
RSUs with performance-based vesting [Member]                  
Stockholders' Equity [Line Items]                  
Stock-based compensation expense | $         $ 11,900